| |
 |
|
| Medical Edge |
|
|
|
Medical Edge Newspaper Column from Mayo Clinic
IMPLANTS OR NOT, MAMMOGRAPHY REMAINS TOP METHOD
FOR BREAST-CANCER DETECTION
DEAR MAYO CLINIC: What is the best way to detect breast cancer
in women with breast implants? Are new technologies superior to the mammogram?
— Via e-mail
ANSWER: The tests recommended for detecting breast cancer are the
same for all patients, whether or not they have breast implants. These
tests include mammography, high-resolution breast ultrasound and breast
MRI (magnetic resonance imaging).
A mammogram is a special X-ray of the breast. Mammogram machines are different
from all other X-ray machines, as they produce “soft” X-rays that do not
penetrate as deeply as regular X-rays. Mammography is the only approved
method for screening the general population, and it is very effective
in detecting early breast cancer in most patients. Mammography is still
the only reliable method of detecting tiny calcium deposits, which can
be cancerous or pre-cancerous.
Breast implants obscure the breast tissue on standard mammography, and
so extra images — with the implants pushed out of the way — are needed.
This means increased radiation exposure for the woman. In addition, when
the fibrous capsule around the implant becomes hard, it’s difficult to
get the implant out of the way. As a result, much less breast tissue is
seen, especially if the implants are in front of the pectoral muscle.
Usually, doctors recommend a breast ultrasound or breast MRI only when
a patient has an abnormal mammogram or is experiencing a breast problem,
such as a lump or discharge of blood from the nipple. Ultrasound uses
high-frequency sound waves to create an image. It can distinguish benign
cysts from other abnormalities, and is frequently used as a guide for
breast procedures such as a biopsy (tissue sampling) or cyst aspiration
(fluid withdrawal).
Breast MRI is a highly technical and expensive test in which a very powerful
magnet is used to obtain hundreds of images of the breasts, before and
after an intravenous injection of dye material. During the study, which
takes an average of 45 minutes, patients must hold very still, as any
movement can make the test less accurate. Breast MRI is very sensitive
and detects both cancerous and non-cancerous lesions. As some cancers
and benign findings can appear similar, breast MRI can lead to unnecessary
biopsies and undue anxiety.
Another test is a PET (positron emission tomography) scan, but it is used
only in those patients already diagnosed with breast cancer. Radioactive
glucose is injected intravenously and a special camera then takes images
of the whole body. Recently, PET scanners have been merged with CT (computed
tomography) scanners. The fused PET-CT images are able to locate an abnormality
with greater precision.
Researchers continue to explore other ways of detecting breast cancer
— for example, sestamibi scintimammography (SSM). Sestamibi is a radioactive
substance used extensively to evaluate blood flow to the heart. Because
intravenous sestamibi can also be taken up by breast tissue, it has been
studied for many years as a possible way to detect breast cancer.
Until recently, SSM (renamed molecular breast imaging by some authors)
could not reliably detect small cancers. Preliminary data with new specialized
cameras suggests that it may be able to pick up smaller cancers that were
previously missed. If substantiated by further research, SSM may be helpful
in detecting breast cancer in combination with — but (ITALICS) not (END
ITALICS) instead of — mammography, ultrasound and MRI.
Another experimental procedure is breast thermography, which uses an infrared
camera to measure temperature differences on the breast surface. Although
approved as safe by the U.S. Food and Drug Administration, it is not approved
as a stand-alone screening test for breast cancer. Also, it is not recognized
by the American Cancer Society or the American College of Radiology as
a reliable diagnostic test, and currently is not covered by insurance.
There is no single perfect test for breast cancer. Although frequently
maligned, mammography is the only test that has been proven to decrease
mortality from breast cancer. Mammography not only remains the mainstay
of breast-cancer detection, it is also critical to the accurate interpretation
of all other breast-imaging studies.
— Patricia J. Karstaedt, M.D., Diagnostic Radiology, Mayo Clinic, Scottsdale,
Ariz.
Additional Resources:
Mammography
Appointment
Information
Breast
Cancer
- - -
Medical Edge from Mayo Clinic is an educational resource and doesn’t
replace regular medical care. To e-mail a question, go to www.mayoclinic.org,
or write: Medical Edge from Mayo Clinic, c/o TMS, 2225 Kenmore Ave., Suite
114, Buffalo, N.Y., 14207. For health information, visit www.mayoclinic.com.
© 2005 TRIBUNE MEDIA SERVICES, INC.
|
|